Trial Profile
A two-arm phase II study of gemcitabine (Gemzarr) in patients with advanced bone sarcomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2006
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 25 Jan 2006 New trial record.